Search Results Search Sort by RelevanceMost Recent History of Medicine Dec 2021 Living Histories of Structural Racism and Organized Medicine Robert Baker, PhD and Matthew K. Wynia, MD, MPH Mistakes and lessons from AMA history situate the AMA now for antiracist leadership in the health care sector. AMA J Ethics. 2021;23(12):E995-1003. doi: 10.1001/amajethics.2021.995. Podcast Dec 2021 Author Interview: “Living Histories of Structural Racism and Organized Medicine” Dr Matthew K. Wynia joins Ethics Talk to discuss his article, coauthored with Dr Robert Baker: “Living Histories of Structural Racism and Organized Medicine” AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940. Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933. Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852. Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021. Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575. Health Law Jun 2022 Survivor-Centered Approaches to Conflict-Related Sexual Violence in International Humanitarian and Human Rights Law Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court. AMA J Ethics. 2022;24(6):E495-517. doi: 10.1001/amajethics.2022.495. Health Law Jun 2022 النُهج المتمحورة حول الناجين من العنف الجنسي المرتبط بالنزاع في القانون الإنساني الدولي وقانون حقوق الإنسان Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil AMA J Ethics. 2022;E495-517. doi: 10.1001/amajethics.2022.495. Case and Commentary Feb 2023 How Should Clinicians Minimize Bias When Responding to Suspicions About Child Abuse? Megan M. Letson, MD, MEd and Kristin G. Crichton, DO, MPH Following evidence-based approaches to evaluating and reporting suspicion of child maltreatment can help minimize bias and promote equity. AMA J Ethics. 2023;25(2):E93-99. doi: 10.1001/amajethics.2023.93. Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next › Last page Last »
History of Medicine Dec 2021 Living Histories of Structural Racism and Organized Medicine Robert Baker, PhD and Matthew K. Wynia, MD, MPH Mistakes and lessons from AMA history situate the AMA now for antiracist leadership in the health care sector. AMA J Ethics. 2021;23(12):E995-1003. doi: 10.1001/amajethics.2021.995.
Podcast Dec 2021 Author Interview: “Living Histories of Structural Racism and Organized Medicine” Dr Matthew K. Wynia joins Ethics Talk to discuss his article, coauthored with Dr Robert Baker: “Living Histories of Structural Racism and Organized Medicine”
AMA Code Says Nov 2020 AMA Code of Medical Ethics’ Opinions Related to Risk Management Ethics Scott J. Schweikart, JD, MBE and Deborah M. Eng, MS, MA Ethical dimensions of risk management are illuminated in AMA Code content on discharge planning. AMA J Ethics. 2020;22(11):E940-944. doi: 10.1001/amajethics.2020.940.
Health Law Nov 2020 How Hospital Leaders and Risk Managers Can Nurture Ethics-Driven Lawyering Norine A. McGrath, MD, Evan G. DeRenzo, PhD, John K. Kilcullen, MD, JD, MPH, and Jack Schwartz, JD Hospital lawyers’ practices shape risk management operations, influence clinicians’ morale, and affect patient care. AMA J Ethics. 2020;22(11):E933-939. doi: 10.1001/amajethics.2020.933.
Case and Commentary Oct 2019 How Should Decision Science Inform Scarce Blood Product Allocation? Eric Kersjes, MD and Lauren B. Smith, MD Decision aids could help clinicians know when to request ethics consultation or re-evaluate blood product usage in a specific patient care situation. AMA J Ethics. 2019;21(10):E852-857. doi: 10.1001/amajethics.2019.852.
Case and Commentary Dec 2019 How Should Physicians Respond When They Learn Patients Are Using Unapproved Gene Editing Interventions? Carolyn Riley Chapman, PhD, MS and Arthur L. Caplan, PhD Responding to patients violating US health commerce regulations can be critical when they buy and use unproven interventions. AMA J Ethics. 2019;21(12):E1021-1028. doi: 10.1001/amajethics.2019.1021.
Case and Commentary Jul 2019 Should Dialysis Be Stopped for an Unrepresented Patient With Metastatic Cancer? Adira Hulkower, JD, MS, Sarah Garijo-Garde, and Lauren S. Flicker, JD, MBE Legal inconsistencies and variation in end-of-life options generate disparities in care for unrepresented patients. AMA J Ethics. 2019;21(7):E575-581. doi: 10.1001/amajethics.2019.575.
Health Law Jun 2022 Survivor-Centered Approaches to Conflict-Related Sexual Violence in International Humanitarian and Human Rights Law Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil During or after conflict, a clinician might be required to provide evidence to an official investigatory body or court. AMA J Ethics. 2022;24(6):E495-517. doi: 10.1001/amajethics.2022.495.
Health Law Jun 2022 النُهج المتمحورة حول الناجين من العنف الجنسي المرتبط بالنزاع في القانون الإنساني الدولي وقانون حقوق الإنسان Klearchos A. Kyriakides, PhD, MPhil and Andreas K. Demetriades, MBBChir, MPhil AMA J Ethics. 2022;E495-517. doi: 10.1001/amajethics.2022.495.
Case and Commentary Feb 2023 How Should Clinicians Minimize Bias When Responding to Suspicions About Child Abuse? Megan M. Letson, MD, MEd and Kristin G. Crichton, DO, MPH Following evidence-based approaches to evaluating and reporting suspicion of child maltreatment can help minimize bias and promote equity. AMA J Ethics. 2023;25(2):E93-99. doi: 10.1001/amajethics.2023.93.